| 产品名称: | Talaromyces marneffei (Segretain et al.) Samson et al. |
|---|---|
| 商品货号: | TS184146 |
| Deposited As: | Penicillium marneffei Segretain et al. |
| Strain Designations: | 302 BM |
| Application: | Biomedical Research and Development Material Emerging infectious disease research |
| Biosafety Level: | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format: | freeze-dried |
| Storage Conditions: | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Type Strain: | no |
| Preceptrol®: | no |
| Comments: | sialic acid-dependent processes |
| Medium: | ATCC® Medium 325: Malt extract agar (Blakeslees formula) ATCC® Medium 336: Potato dextrose agar (PDA) ATCC® Medium 2003: Czapek yeast extract agar |
| Growth Conditions: | Temperature: 24°C to 26°C Atmosphere: Typical aerobic |
| Name of Depositor: | N Vanittanakom |
| Special Collection: | NCRR Contract |
| Chain of Custody: | ATCC <-- N Vanittanakom <-- C. Khumwan |
| Isolation: | Bone marrow from AIDS patient, Chiang Mai, Thialand |
| References: | Hamilton AJ, et al. Recognition of fibronectin by Penicillium marneffei conidia via a sialic acid-dependent process and its relationship to the interaction between conidia and laminin. Infect. Immun. 67: 5200-5205, 1999. PubMed: 10496896 Lasker BA. Nucleotide sequence-based analysis for determining the molecular epidemiology of Penicillium marneffei. J Clin Microbiol 44: 3145-3153, 2006. PubMed: 16954240 |